Pediatric IgA nephropathies: Clinical aspects and therapeutic approaches;Néphropathies à dépôts dIgA en pédiatrie: Aspects cliniques et approches thérapeutiques

EMC - Nephrologie

Volumn 2, Issue 1, 2005, Pages 12-30

  Delos Santos, N M ^a,b   Wyatt, R J ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

Berger's disease; Henoch Schonlein purpura; Immunoglobulin A deposits; Nephropathy

Indexed keywords

EID: 32544438353     PISSN: 16386248     EISSN: 16386248     Source Type: Journal    
DOI: 10.1016/j.emcnep.2004.12.001     Document Type: Short Survey

References (160)

1. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987;64:709-27.
2. Utsunomiya Y, Kado T, Koda T, Okada S, Hayashi A, Fukawaza A, et al. Features of IgA nephropathy In pre-school children. Clin Nephrol 2000;54:443-8.
3. Yoshikawa N, Tanaka R, Iijima K. Pathophysiology and treatment of IgA nephropathy in children. Pediatr Nephrol 2001; 16:446-57.
4. Cho BS, Kim SD, Choi YM, Kang HH. School urinalysis screening in Korea: prevalence of chronic renal disease. Pediatr Nephrol 2001; 16:1126-8.
5. Wyatt RJ, Julian BA, Baehler RW, Stafford CC, McMorrow RG, Ferguson T, et al. Epidemiology of IgA nephropathy in central and eastern Kentucky for the period 1975 through 1994. J Am Soc Nephrol 1998;9:853-8.
6. Clarkson AR. IgA nephropathy: history, classification, and geographical distribution. In: Clarkson AR, editor. IgA nephropathy, Boston: Martinus Nijhoff; 1987. p. 1-8.
7. Jennette JC, Wall SD, Wilkman AS. Low incidence of IgA nephropathy in blacks. Kidney Int 1985;28:944-50.
8. Seedat YK, Nathoo BC, Parag KB, Naiker IP, Ramsaroop R. IgA nephropathy in blacks and Indians of Natal. Nephron 1988:50:137-41.
9. Oviasu E. IgA nephropathy (IgAN) presenting with the nephritic syndrome. Trop Geogr Med 1992;44:365-8.
10. rd S, Miller PM, Kritchevsky SB, Wyatt RJ. Increased recognition of IgA nephropathy In African-American children. Pediatr Nephrot 1997;11: 435-7.
11. Utsunomiya Y, Koda T, Kado T, Okada S, Hayashi A, Kanzaki S, et al. Incidence of pediatric IgA nephropathy, Pediatr Nephrol 2003;18:511-5.
12. Berger J. IgA glomerular deposits in renal disease. Transplant Proc 1968; 1:939-44.
13. Levy M, Beaufils H, Gubler MC, Habib R. Idiopathic recurrent macroscopic hematuria and mesangial IgA-IgG depos-its in children (Berger's disease). C;in Nephrol 1972;1: 63-9.
14. Wyatt RJ, Julian BA, Bhathena DB, Mitchell BL, Holland NH, Malluche HH. IgA nephropathy: presentation, clinical course and prognosis in children and adults. Am J Kidney Dis 1984;4:192-200.
15. Kher KK, Makker SP, Moorthy B. IgA nephropathy (Berger's disease): a clinicopathologic study in children. Int J PediatrNep/iro/1983;4:11-8.
16. Levy M, Gonzalez-Burchard G, Broyer M, Dommergues JP, Foulard M, Sorez JP, et al. Berger's disease in children. Medicine 1985;64:157-80.
17. Berg UB. Long-term follow-up of renal function in IgA nephropathy. Arch Dis Child 1991;66:588-92.
18. Southwest Pediatric Nephrology Study Group. A multi-center study of IgA nephropathy in children. Kidney Int 1982; 22:643-52.
19. Hogg RJ, Silva FG, Wyatt RJ, Reisch JS, Argyle JC, Savino DA. Prognostic indicators in children with IgA nephropathy: report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 1994;8:15-20.
20. Wyatt RJ, Kritchevsky SB, Woodford SY, Miller PM, Roy 3rd S, Holland NH, et al. IgA nephropathy: long-term prognosis for pediatric patients. J Pediatr 1995; 127:913-9.
21. Kitajima T, Murakami M, Sakai O. Clinicopathological features in Japanese patients with IgA nephropathy. Jpn J Med 1983;22:219-22.
22. Kusumoto Y, Takebayashi S, Taguchi T, Harada T, Naito S. Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and adult Japanese. Clin Nephrol 1987; 28:118-24.
23. Yoshikawa N, Ito H, Yoshiara S, Nakahara C, Yoshiya K, Hasegawa O, et al. Clinical course of immunoglobulin A nephropathy in children. J Pediatr 1987;110:555-60.
24. Yoshikawa N, Ito H, Nakamura H. IgA nephropathy in children from Japan. Child Nephrol Ural 1989;9:191-9.
25. Yoshikawa N, Ito H, Nakamura H. Prognostic indicators in childhood IgA nephropathy. Nephron 1992;60:60-7.
26. Hisano S, Kawano M, Kaku Y, Yamane I, Hatae K, Uragoh K, et al. The natural history of screening detected IgA glome-rulonephritis in children. Acta Paediatr Scand 1991;80: 1044-50.
27. Stapleton FB, Roy III S, Noe HN, Jerkins G. Hypercalciuria in children with hematuria. N Engl J Med 1984;310:1345-8.
28. Tasic V, Korneti P, Ristoska-Bojkovska N, Petrusevska G, Polenakovic M. Idiopathic hypercalciuria preceding IgA nephritis in a child with recurrent hematuria. Pediatr Nephrol 2003; 18:394-6.
29. Southwest Pediatric Nephrology Study Group. Association of IgA nephropathy with steroid-responsive nephrotic syndrome. Am J Kidney Dis 1985;5:157-64.
30. Wyatt RJ, Hogg RJ. Evidence-based assessment of treatment options for children with IgA nephropathies. Pediatr Nephrol 2001; 16:156-67.
31. Task Force on Blood Pressure Control in Children, National Heart, Lung, and Blood Institute. Report of the Second Task Force on Blood Pressure Control In Children. Pediatrics 1976; 58:259-63.
32. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 1998;98:649-58.
33. Santos NM, Ault BH, Gharavi AG, Kritchevsky SB, Quasney MW, Jackson EC, etal. Angiotensin-converting enzyme genotype and outcome in pediatric IgA nephropathy. Pediatr Nephrol 2002; 17:496-502.
34. Welch TR, McAdams J, Berry A. Rapidly progressive IgA nephropathy. Am J Dis Child 1988; 142:789-93.
35. Radford Jr. MG, Donadio Jr. JV, Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Neplvol 1997;8:199-207.
36. Haas M. Histological subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997;29:829-42.
37. McEnery PT, McAdams AJ, West CD. Glomerular morphology, natural history and treatment of children with IgA-IgG mesangial nephropathy. In: Kincaid-Smith P, Mathew TH, Becker EL, editors. Glomerulonephritis: natural history and treatment. New York: Wiley; 1972. p. 305-20.
38. Michalk D, Waldherr R, Seelig HP, Weber HP, Scharer K. Idiopathic mesangial IgA-glomerulonephritis in childhood: description of 19 pediatric cases and review of the literature. Eur J Pediatr 1980; 134:13-22.
39. Linne T, Aperia A, Broberger O, Bergstrand A, Bohman SO, Rekola S. Course of renal function in IgA glomerulonephritis in children and adolescents. Acta Paediatr Scand 1982; 71:735-43.
40. Ariceta G, Gallego N, Lopez-Fernandez Y, Vallo A, Quintela MJ, Rodriguez Soriano J. Long-term prognosis of childhood IgA nephropathy in adult life. Med Clin 2001;116: 361-4.
41. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histologie prognostic factors. Am J Kidney Dis 2000;36:227-37.
42. Beukhof JR, Ockhuizen T, Halie LM, Westra J, Beelen JM, Donker AJ, et al. Subentities within adult primary IgA-nephropathy. Clin Nephrol 1984;22:195-9.
43. Zidar N, Cavic MA, Kenda RB, Koselj M, Ferluga D. Effect of intrauterine growth retardation on the clinical course and prognosis of IgA glomerulonephritis in children. Nephron 1998;79:28-32.
44. Lee SM, Rao VM, Franklin WA, Schiffer MS, Aronson AJ, Spargo BH, et al. IgA nephropathy: morphologic predictors of progressive disease. Hum Pathol 1982; 13:314-22.
45. Wyatt RJ, Emancipator SN, Kon V, Waldo FB, Donadio J, Grande JP, et al. IgA nephropathy Databank: development of a system for management of renal biopsy acquired data. Am J Kidney Dis 1997;29:817-28.
46. Andreoli SP, Yum MN, Bergstein JM. IgA nephropathy in children: significance of glomerular basement membrane deposition of IgA. Am J Nephrol 1986;6:28-33.
47. Yoshikawa N, Ito H, Yoshiya K, Nakahara C, Yoshiara S, Hasegawa 0, et al. Henoch-Schönlein nephritis and IgA nephropathy in children: a comparison of clinical course. Clin Nephrol 1987;27:233-7.
48. Toth T, Takebayashi S. Glomerular hypertrophy as a prognostic marker in childhood IgA nephropathy. Nephron 1998;80:285-91.
49. Watanabe T, Kawachi H, Ikezumi Y, Yanagihara T, Oda Y, Shimizu F, Glomerular CD8+ cells predict progression of childhood IgA nephropathy, Pediatr Nephrol 2001; 16: 561-7.
50. Nagata M, Akioka Y, Tsunoda Y, Komatsu Y, Kawaguchi H, Yamaguchi Y, et al. Macrophages In childhood IgA nephropathy. Kidney Int 1995;48:527-35.
51. Schena FP, D'Altri C, Cerullo G, Manno C, Gesualdo L. ACE gene polymorphism and IgA nephropathy: an ethnically homogeneous study and meta-analysls. Kidney Int 2001; 60:732-40.
52. Rigat B, Hubert C, Alhenc-Gelas F, Camblen F, Corvol P, Soubrier F. An Insertion/deletion polymorphism in the anglotensln l-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343 6.
53. Tanaka R, Iijlma K, Murakaml R, Koide M, Nakamura H, Yoshikawa N, ACE gene polymorphism in childhood IgA: association with cllnlcopathologic findings. Am J Kidney Dis 1998;31:774-9.
54. Asano T, Tatsuma N, Yoshida J, Ohashi R, Ambo K, Tsuchiya M, et al. Association of anglotensin-converting enzyme gene polymorphism and renal pathology In Japanese children with IgA nephropathy. Clin Nephrol 1999;51: 335-40.
55. Maruyama K, Yoshida M, Nishlo H, Shlrakawa T, Kawamura T, Tanaka R, et al. Polymorphisms of reninangiotensin system genes In childhood IgA nephropathy. Pediatr Nephrol 2001;16:350-5.
56. Shlmomura M, Yoshlkawa N, Iijima K, Nakamura H, Miyazaki M, Sakai H. Polymorphism of Immunoglobulin heavy chain switch region gene in children with severe IgA nephropathy. Clin Nephrol 1995;43:211-5.
57. Tanaka R, Iijima K, Xu H, Inoue Y, Murakami R, Shirakawa T, et al. Role of platelet-activating factor acetylhydrolase gene mutation in Japanese childhood IgA nephropathy. Am J Kidney Dis 1999; 34:289-95.
58. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989; 95(suppl2):2S-4S.
59. Rodicio JL, Alcazar JM, Ruilope LM. Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria. Kidney Int 1990;38:590-4.
60. Heeg JE, de Jong PE, Van der Hem GK, de Zeeuw D. Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 1987;32:78-83.
61. Remuzzi A, Perico N, Sangalli F, Vendramin G, Moriggi M, Ruggenenti P, et al. ACE inhibition and ANG II receptor blockade improve glomerulur size-selectivity in IgA nephropathy. Am J Physiol 1999;276:F457-F466.
62. Nolin L, Courteau M. Management of IgA nephropathy: evidence-based recommendations. Kidney Int 1999; 70(suppl):S56-62.
63. Floege J. Evidence-based recommendations for immuno-suppression in IgA nephropathy: handle with caution. Nephrol Dial Transplant 2003;18:241-5.
64. Hebert LA, Wilmer WA, Falkenhain ME, Ladson-Wofford SE, Nahman Jr NS, Rovin BH. Renoprotection: one or many therapies? Kidney Int 2001:59:1211-26.
65. Glassock RJ. Treatment of IgA nephropathy: status at the end of the millennium. J Nephrol 1999;12:288-96.
66. Julian BA. Treatment of IgA nephropathy. Semin Nephrol 2000;20:277-85.
67. Bhattacharjee R, Filler G. Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy. Pediatr Nephrol 2002; 17:302-4.
68. Hogg RJ, Wyatt RJ. A randomized controlled trial of mycophenolate mofetil In patients with IgA nephropathy. [IRSCTN 6256616]. BMC Nephrol 2004; 5:3.
69. Coppo R, Chiesa M, Peruzzi L, Amore A. Treatment of IgA nephropathy with angiotensin converting enzyme inhibitors: design of a prospective randomized multicenter trial. J Nephrol 2001; 14:447-52.
70. Itami N, Akutsu Y, Kusunoki Y, Tochimaru H, Takekashi Y. Does methylprednisolone pulse therapy deteriorate the course if rapidly progressive IgA nephropathy? Am J Dis Child 1989; 143:441-2.
71. Boobes Y, Baz M, Durand C, Jaber K, Goldstein P, Berland Y. Early start of intensive therapy in malignant form of IgA nephropathy. Nephron 1990;54:351-3.
72. Niaudet P, Murcia I, Beaufils H, Broyer M, Habib R. Primary IgA nephropathies in children: prognosis and treatment. Adv Nephrol Necker Hosp 1993;22:121-40.
73. Roccatello D, Ferro M, Coppo R, Giraudo G, Quattrocchio G, Piccoli G. Report on intensive treatment of extra-capillary glomerulonephritis with focus on crescentic IgA nephropathy. Nephrol Dial Transplant 1995; 10:2054-9.
74. Waldo FB, Alexander R, Wyatt RJ, Kohaut EC. Alternateday prednisone therapy in children with IgA-associated nephritis. Am J Kidney Dis 1989;13:55-60.
75. Waldo FB, Wyatt RJ, Kelly DR, Herrera GA, Benfield MR, Kohaut EC. Treatment of IgA nephropathy in children: efficacy of alternate-day oral prednisone. Pediatr Nephrot 1993:7:529-32.
76. Tanaka H, Waga S, Yokoyama M. Age-related histologic alterations after prednisolone therapy in children with IgA nephropathy. Tohoku J Exp Med 1998; 185:247-52.
77. Welch TR, Fryer C, Shely E, Witte DP, Quintan M. Double-blind, controlled trial of short-term prednisone therapy in immunoglobulin A glomerulonephritis. J Pediatr 1992; 121: 474-7.
78. Hogg RJ. A randomized, placebo-controlled, multicenter trial evaluating alternate-day prednisone and fish oil supplements in young patients with immunoglobulin A nephropathy. Scientific Planning Committee of the IgA Nephropathy Study. Am J Kidney Dis 1995;26:792-6.
79. Hogg RJ, Lee J, Nardelli NA, Cattran D, Hirschman G, Julian BA. Multicenter, placebo-controlled trial of alternate-day prednisone (QOD-PRED) or daily omega3 fatty acids (OM-3 FA) in children and young adults with IgA nephropathy (IgAN). Report from the Southwest Pediatric Nephrology Study Group. J Am Soc Nephrol 2003; 14: 751A [abstract].
80. Andreoli SP, Bergstein JM. Treatment of severe IgA nephropathy in children. Pediatr Nephrol 1989;3:248-53.
81. Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, et al. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. J Am Soc Nephrol 1999;10:101-9.
82. Rasche FM, Schwarz A, Keller F. Tonsillectomy does not prevent a progressive course in IgA nephropathy. Clin Nephrol 1999;51:147-52.
83. Xie Y, Nishi S, Ueno M. The efficacy of tonsillectomy on long-tern survival in patients with IgA nephropathy. Kidney Int 2003;63:1861-7.
84. Chan JC, Mahan JD, Trachtman H, Scheinman J, Flynn JT, Alon US, et al. Vitamin E therapy in IgA nephropathy: a double-blind, placebo-controlled study. Pediatr Nephrol 2003;18:1015-9.
85. Levy M, Broyer M, Arsan A, Levy-Bentolila D, Habib R. Anaphylactoid purpura nephritis in childhood: natural history and immunopathology. Adv Nephrol Necker Hasp 1976;6:183-228.
86. Nakamoto Y, Asano Y, Dohi K, Fujioka M, Mda H, Kida H, et al Primary IgA glomerulonephritls and Schönlein-Henoch purpura nephritis: clinlcopathological and immunohlstologlcal characteristics. Q J Med 1978;47:495-516.
87. Waldo FB. Is Henoch-SchOnlein purpura the systemic form of IgA nephropathy? Am J Kidney Dis 1988; 12:373-7.
88. Meadow SR, Scott DG. Berger disease: Henoch-Schonlein syndrome without the rash. J Pediatr 1985; 106:27-31.
89. Hughes FJ, Wolfish NM, McLalne PN. Henoch-Schonlein syndrome and IgA nephropathy: a case report suggesting a common pathogenesis. Pediatr Nephrol 1988;2:389-92.
90. Kaneko K, Suzuki Y, Kiya K, Fukuda Y, Yabuta K. A case report suggesting a common pathogenesis for IgA nephropathy and Henoch-Schonlein purpura. Pediatr Nephrol 1994; 8:750-1.
91. Watanabe T, Takada T, Kihara I, Oda Y. Three cases of Henoch-Schonlein purpura preceded by IgA nephropathy. Pediatr Nephrol 1995;9:674.
92. Stewart M, Savage JM, Bell B, McCord B. Long term renal prognosis of Henoch-Schonlein purpura In an unselected childhood population. Eur J Pediatr 1988; 147:113-5.
93. Nielsen HE. Epidemiology of Schonleln-Henoch purpura. Acta Paediatr Scand 1988;77:125-31.
94. Calvino MC, Llorca J, Garcia-Porrua C, Fernandez-Iglesias JL, Rodrlguez-Ledo P, Gonzalez-Gay MA. Henoch-Schonlein purpura In children from northwestern Spain. A 20-year epidemiologic and clinical study. Medicine 2001; 80:279-90.
95. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculltldes In children of different ethnic origins. Lancet 2002;360:1197-202.
96. Abdel-Al YK, Hejazi Z, Majeed HA. Henoch Schönlein purpura In Arab children. Analysis of 52 cases. Trop Geogr Med 1990; 42:52-7.
97. Al-Sheyyab M, El-Shanti H, Ajlouni S, Batieha A, Daoud AS. Henoch-Schonlein purpura: clinical experience and contemplations on a streptococcal association. J Trop Pediatr 1996;42:200-3.
98. Farley TA, Gillespie S, Rasoulpour M, Tolentino N, Hadler JL, Hurwitz E. Epidemiology of a cluster of Henoch-Schonlein purpura. Am J Dis Child 1989;143:798-803.
99. Saulsbury FT. Henoch-Schonlein purpura in children: report of 100 patients and review of the literature. Medicine1999;78:395-409.
100. Heberden W. In: Commentari di morborium historia et curatione, Payne, London 1801. Reprinted as "Commentaries on the History and Cure of Diseases. ". Birmingham, AL: The Classics of Medicine Library, Division of Gryphon Editions Ltd; 1982. p. 395-7.
101. Schonlein JL. Allgemeine und specielle Pathologie und Therapie. Wurzburg: Herisau; 1837 48p.
102. Henoch E. Uber eine eigenthumliche Form von Purpura. Berl Klin Wochnschr 1874; 11:641-3.
103. Henoch E. Vorlesungen uber Kinderkrankheiten. Berlin: Hirschward A; 1899839p.
104. Osler W. Visceral lesions of purpura and allied conditions. BMJ 1914;1:517-25.
105. Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 1990;33:1114-21.
106. Michel BA, Hunder GG, Bloch DA, Calabrese LH. Hypersensitivity vasculitis and Henoch-Schonlein purpura: a comparison between the two disorders. J Rheumatol 1992; 19: 721-8.
107. Evans DJ, Williams DG, Peters DK, Sissons JG, Boulton-Jones JM, Ogg CS, et al. Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. BMJ 1973;3:326-8.
108. Urizar RE, Michael A, Sisson S, Vernier RL Anaphylactoid purpura II. Immunofluorescent and electron microscopy studies of the glomerular lesions. Lab Invest 1968; 19:437-40.
109. Kobayashi O, Wada H, Okawa K, Takeyama I. SchönleinHenoch's syndrome in children. Contrib Nephrol 1975;4: 48-71.
110. West CD, McAdams AJ, Welch TR. Glomerulonephritis in Henoch- Schönlein purpura without mesangial IgA deposition. Pediatr Nephrol 1994;8:677-83.
111. Heaton JM, Turner DR, Cameron JS. Localization of glomerular "deposits" in Henoch-Schönlein nephritis. Histopathology 1977; 1:93-104.
112. Oliver Jr TK, Barnett HL Incidence and prognosis of nephritis associated with anaphylactoid (Schönlein-Henoch purpura in children. Am J Dis Child 1955;90:544-7.
113. Wedgewood RJ, Klaus MH. Anaphylactoid purpura. A long term follow-up study with special reference to renal involvement. Pediatrics 1955; 16:196-206.
114. Allen DM, Diamond LK, Howell DA. Anaphylactoid purpura in children (Schönlein-Henoch syndrome). Am J Dis Child 1960;99:833-54.
115. Koskimies O, Mir S, Rapola J, Vilska J. Henoch-Schönlein nephritis: long-term prognosis of unselected patients. Arch Dis Child 1981;56:482-4.
116. Zurowska AM, Wrzolkowa T, Uszycka-Karcz M. Henoch-Schönlein nephritis in children: a clinicopathological study. Int J Pediatr Nephrol 1985;6:183-8.
117. Kaku Y, Nohara K, Honda S. Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic features. Kidney Int 1998;53:1755-9.
118. Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura. Eur J Pediatr 2002;161:196-201.
119. Meadow SR, Glasgow EF, White RH, Moncrieff MW, Cameron JS, Ogg CS. Schönlein Henoch nephritis. Q J Med 1972;41:241-58.
120. Hurley RM, Drummond KM. Anaphylactoid purpura nephritis: clinicopathological correlations. J Pediatr 1972; 81:904-11.
121. Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, et al. Prognosis of Henoch-Schönlein nephritis in children. BMJ 1977;2:11-4.
122. Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP. Long-term prognosis of Henoch Schönlein nephritis in adults and children. Nephrol Dial Transplant 1997; 12: 2277-83.
123. Goodyer PR, De Chadarevian JP, Kaplan BS. Acute post-streptococcal glomerulonephritis mimicking Henoch-Schönlein purpura. J Pediatr 1978;93:412-5.
124. Onisawa S, Morishima N, Ichimura T. Concurrent poststreptococcal acute glomerulonephritis and Schönlein-Henoch purpura. Acta Paediatr Jpn 1989;31:487-92.
125. Masuda M, Nakanishi K, Yoshizawa N, Iijima K, Yoshikawa N. Group A streptococcal antigen in the glomeruli of children with Henoch-Schönlein nephritis. Am J Kidney Dis 2003;41:366-70.
126. Bunchman TE, Mauer SM, Sibley RK, Vernier RL. Anaphylactoid purpura: characteristics of 16 patients who progressed to renal failure. Pediatr Nephrol 1988;2:393-7.
127. Goldstein AR, White RH, Akuse R, Chantier C. Long-term follow-up of childhood Henoch-Schönlein purpura nephritis. Lancet 1992;339:280-2.
128. Scharer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F. Clinical outcome of Schönlein-Henoch purpura nephritis in children. Pediatr Nephrol 1999;13:816-23.
129. Ronkainen J, Nututinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schönlein purpura: a ret-rospective study. Lancet 2002;360:666-70.
130. Algoet C, Proesmans W. Renal biopsy 2-9 years after Henoch Schönlein purpura. Pediatr Nephrol 2003; 18: 471-3.
131. Pabunruang W, Treepongkaruna S, Tangnararatchakit K, Chunharas A, Phuapradit P. Henoch-Schönlein purpura: clinical manifestations and long-term outcomes in Thai children. J Med Assoc Thai 2002;85(suppl4):S1213-8.
132. Mestecky J, Tomana M, Crowley-Nowick PA, Moldoveanu Z, Julian BA, Jackson S. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 1993;104:172-82.
133. Tomana M, Matousovic K, Julian BA, Radl J, Konecny K, Mestecky J. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 1997;52:509-16.
134. Saulsbury FT. Alterations in the O-linked glycosylation of IgA1 in children with Henoch-Schönlein purpura. J Rheumoto/1997;24:2246-9.
135. Alien AC, Willis FR, Beattie TJ, Feehally J. Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 1998;13:930-4.
136. Muller D, Greve D, Eggert P. Early tubular proteinuria and the development of nephritis in Henoch-Schönlein purpura. Pediatr Nephrol 2000; 15:85-9.
137. Namgoong MK, Lim BK, Kim JS. Eosinophilic cationic protein in Henoch-Schönlein purpura and in IgA nephropathy. Pediatr Nephrol 1997; 11:703-6.
138. Fujieda M, Oishi N, Naruse K, Hashizume M, Nishiya K, Kurashige T, et al. Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Schönlein purpura. Arch Dis Child 1998;78:240-4.
139. Besbas N, Saatci U, Ruacan S, Ozen S, Sungur A, Bakkaloglu A, et al. The role of cytokines in Henoch-Schönlein purpura. Scand J Rheumatol 1997;26:456-60.
140. Muslu A, Islek I, Gok F, Aliyazicioglu Y, Dagdemir A, Dundaroz R, et al. Endothelin levels in Henoch-Schönlein purpura. Pediatr Nephrol 2002;17:920-5.
141. White RH. Henoch-Schönlein purpura nephritis: a disease with significant late sequelae. Nephron 1994;68:1-9.
142. Kumada K, Suzuki J, Kume K, Suzuki S, Yoshida K, Isome M, et al. Clinicopathological study of Henoch-Schönlein purpura nephritis with special reference to C3c deposits. Nippon Jinzo Gakkai Shi 1996;38:259-68.
143. Amoroso A, Danek G, Vatta S, Crovella S, Berrino M, Guarrera S, et al. Polymorphisms in angiotensin-converting enzyme gene and severity of renal disease in Henoch-Schönlein patients. Italian Group of Renal Immunopathology. Nephrol Dial Transplant 1998;13:3184-8.
144. Brodkiewicz A, Ciechanowicz A, Urbanska A, Peregud-Pogorzelski J, Dzienski P, Subicka D, et al. The I/D polymorphism of the ACE gene in children with HenochSchönlein purpura. Pol Merckuriusz Lex 2000;8:236-8.
145. Dudley J, Afifi E, Gardner A, Tizard EJ, McGraw ME. Polymorphism of the ACE gene in Henoch-Schönlein purpura nephritis. Pediatr Nephrol 2000;14:218-20.
146. Yoshioka T, Xu YX, Yoshida H, Shiraga H, Muraki T, Ito K. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis. Arch Dis Child 1998;79:394-9.
147. Amoli MM, Thomson W, Hajeer AH, Calvino MC, Garcia-Porrua C, Ollier WE, et al. Interleukln 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura. J Rheumatol 2002; 29:1404-7.
148. rd S, McLean RH, et al. Association of Henoch-Schönlein purpura glomerulonephritis and C4B deficiency. J Pediatr 1990; 117:753-5.
149. Buchanec J, Galanda V, Belakova S, Minarik M, Zibolen M. Incidence of renal complications in Schönlein-Henoch purpura syndrome in dependence on an early administration of steroids. Int Urol Nephrol 1988;20:409-12.
150. Mollica F, Li Volti S, Garozzo R, Russo G. Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr 1992;151:140-4.
151. Saulsbury FT. Corticosteroid therapy does not prevent nephritis in Henoch-Schönlein purpura. Pediatr Nephrol 1993;7:69-71.
152. Oner A, Tinaztepe K, Erdogan O. The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis. Pediatr Nephrol 1995;9:6-10.
153. Niaudet P, Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch pur-pura nephritis. Pediatr Nephrol 1998; 12:238-43.
154. Bergstein J, Leiser J, Andreoli SP. Response of crescentic Henoch-Schönlein purpura nephritis to corticosteroid and azathioprine therapy. Clin Nephrol 1988;49:9-14.
155. Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N. Multiple combined therapy for severe Henoch-Schönlein nephritis in children. Pediatr Nephrol 1998; 12:244-8.
156. Hattori M, Ito K, Konomoto T, Kawaguchi H, Yoshioka T, Khono M. Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children. Am J Kidney Dis 1999;33:427-33.
157. Tanaka H, Suzuki K, Nakahata T, Ito E, Waga S. Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol 2003; 18:347-50.
158. Foster BJ, Bernard C, Drummond KN, Sharma AK. Effective therapy for severe Henoch-Schönlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 2000;136:370-5.
159. Watanabe T, Takahashi S, Nakajo S, Hamasaki M. Pathological improvement of IgA nephropathy and Henoch-Schönlein purpura nephritis with urokinase therapy. Acta Paediatr Jpn 1996;38:622-8.
160. Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H. Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis. Pediatrics 2003;111(4Pt1):785-9.